Go Pro
→ MILLIONAIRE MASTERCLASS INVITE: Altucher (From Paradigm Press) (Ad)tc pixel Free FUM Stock Alerts

Futura Medical (FUM) Competitors

Futura Medical logo
GBX 0.22 +0.02 (+10.00%)
As of 07:45 AM Eastern
Compare

FUM vs. TLM, NFX, BNR, MTFB, and DEST

Should you buy Futura Medical stock or one of its competitors? Futura Medical's main competitors and comparable companies include Talisman Metals (TLM), Nuformix (NFX), Burning Rock Biotech (BNR), Motif Bio (MTFB), and Destiny Pharma (DEST). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "biotechnology" industry.

How does Futura Medical compare to Talisman Metals?

Talisman Metals (LON:TLM) and Futura Medical (LON:FUM) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their dividends, institutional ownership, profitability, media sentiment, analyst recommendations, earnings, valuation and risk.

Talisman Metals has higher earnings, but lower revenue than Futura Medical. Futura Medical is trading at a lower price-to-earnings ratio than Talisman Metals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Talisman MetalsN/AN/A-£1.35M£12.390.65
Futura Medical£2.32M0.55-£3.88M-£0.81N/A

Talisman Metals has a beta of 0.9, suggesting that its stock price is 10% less volatile than the broader market. Comparatively, Futura Medical has a beta of 0.021, suggesting that its stock price is 98% less volatile than the broader market.

1.4% of Talisman Metals shares are held by institutional investors. Comparatively, 1.0% of Futura Medical shares are held by institutional investors. 95.2% of Talisman Metals shares are held by insiders. Comparatively, 16.0% of Futura Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Talisman Metals has a net margin of 0.00% compared to Futura Medical's net margin of -158.21%. Talisman Metals' return on equity of 0.00% beat Futura Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Talisman MetalsN/A N/A 3.70%
Futura Medical -158.21%-152.42%-26.59%

In the previous week, Talisman Metals' average media sentiment score of 0.00 equaled Futura Medical'saverage media sentiment score.

Company Overall Sentiment
Talisman Metals Neutral
Futura Medical Neutral

Summary

Talisman Metals beats Futura Medical on 9 of the 10 factors compared between the two stocks.

How does Futura Medical compare to Nuformix?

Futura Medical (LON:FUM) and Nuformix (LON:NFX) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, media sentiment, dividends, analyst recommendations, valuation, risk and profitability.

Futura Medical has a beta of 0.021, suggesting that its stock price is 98% less volatile than the broader market. Comparatively, Nuformix has a beta of 1.531, suggesting that its stock price is 53% more volatile than the broader market.

1.0% of Futura Medical shares are held by institutional investors. Comparatively, 0.1% of Nuformix shares are held by institutional investors. 16.0% of Futura Medical shares are held by company insiders. Comparatively, 7.5% of Nuformix shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Nuformix has lower revenue, but higher earnings than Futura Medical. Nuformix is trading at a lower price-to-earnings ratio than Futura Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Futura Medical£2.32M0.55-£3.88M-£0.81N/A
NuformixN/AN/A-£383.40K-£0.03N/A

Nuformix has a net margin of 0.00% compared to Futura Medical's net margin of -158.21%. Nuformix's return on equity of -83.53% beat Futura Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Futura Medical-158.21% -152.42% -26.59%
Nuformix N/A -83.53%-17.20%

In the previous week, Futura Medical's average media sentiment score of 0.00 equaled Nuformix'saverage media sentiment score.

Company Overall Sentiment
Futura Medical Neutral
Nuformix Neutral

Summary

Nuformix beats Futura Medical on 6 of the 10 factors compared between the two stocks.

How does Futura Medical compare to Burning Rock Biotech?

Futura Medical (LON:FUM) and Burning Rock Biotech (LON:BNR) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, valuation, profitability, institutional ownership, risk, analyst recommendations, earnings and media sentiment.

1.0% of Futura Medical shares are owned by institutional investors. 16.0% of Futura Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Futura Medical's average media sentiment score of 0.00 equaled Burning Rock Biotech'saverage media sentiment score.

Company Overall Sentiment
Futura Medical Neutral
Burning Rock Biotech Neutral

Burning Rock Biotech has a net margin of 0.00% compared to Futura Medical's net margin of -158.21%. Burning Rock Biotech's return on equity of 0.00% beat Futura Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Futura Medical-158.21% -152.42% -26.59%
Burning Rock Biotech N/A N/A N/A

Burning Rock Biotech has lower revenue, but higher earnings than Futura Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Futura Medical£2.32M0.55-£3.88M-£0.81N/A
Burning Rock BiotechN/AN/AN/AN/AN/A

Summary

Futura Medical and Burning Rock Biotech tied by winning 3 of the 6 factors compared between the two stocks.

How does Futura Medical compare to Motif Bio?

Motif Bio (LON:MTFB) and Futura Medical (LON:FUM) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, analyst recommendations, profitability, earnings, risk, institutional ownership, dividends and valuation.

1.0% of Futura Medical shares are held by institutional investors. 16.0% of Futura Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Motif Bio's average media sentiment score of 0.00 equaled Futura Medical'saverage media sentiment score.

Company Overall Sentiment
Motif Bio Neutral
Futura Medical Neutral

Motif Bio has a net margin of 0.00% compared to Futura Medical's net margin of -158.21%. Motif Bio's return on equity of 0.00% beat Futura Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Motif BioN/A N/A N/A
Futura Medical -158.21%-152.42%-26.59%

Motif Bio has higher earnings, but lower revenue than Futura Medical. Futura Medical is trading at a lower price-to-earnings ratio than Motif Bio, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Motif BioN/AN/AN/A-£19.20N/A
Futura Medical£2.32M0.55-£3.88M-£0.81N/A

Summary

Motif Bio and Futura Medical tied by winning 4 of the 8 factors compared between the two stocks.

How does Futura Medical compare to Destiny Pharma?

Futura Medical (LON:FUM) and Destiny Pharma (LON:DEST) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, risk, dividends, valuation, media sentiment, analyst recommendations, earnings and institutional ownership.

In the previous week, Futura Medical's average media sentiment score of 0.00 equaled Destiny Pharma'saverage media sentiment score.

Company Overall Sentiment
Futura Medical Neutral
Destiny Pharma Neutral

1.0% of Futura Medical shares are owned by institutional investors. Comparatively, 21.9% of Destiny Pharma shares are owned by institutional investors. 16.0% of Futura Medical shares are owned by company insiders. Comparatively, 25.9% of Destiny Pharma shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Futura Medical has higher revenue and earnings than Destiny Pharma. Futura Medical is trading at a lower price-to-earnings ratio than Destiny Pharma, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Futura Medical£2.32M0.55-£3.88M-£0.81N/A
Destiny Pharma£135.03K0.00-£5.66M-£0.06N/A

Destiny Pharma has a net margin of 0.00% compared to Futura Medical's net margin of -158.21%. Destiny Pharma's return on equity of -67.29% beat Futura Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Futura Medical-158.21% -152.42% -26.59%
Destiny Pharma N/A -67.29%-44.90%

Futura Medical has a beta of 0.021, meaning that its stock price is 98% less volatile than the broader market. Comparatively, Destiny Pharma has a beta of 0.22, meaning that its stock price is 78% less volatile than the broader market.

Summary

Destiny Pharma beats Futura Medical on 6 of the 10 factors compared between the two stocks.

Get Futura Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for FUM and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FUM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FUM vs. The Competition

Export
MetricFutura MedicalBiotechnology IndustryHealthcare SectorLON Exchange
Market Cap£1.28M£3.98B£7.31B£2.89B
Dividend Yield4.55%3.63%2.52%6.22%
P/E Ratio-0.2713.88274.10366.58
Price / Sales0.551,437.48672.6190,068.21
Price / Cash20.43113.2977.8027.89
Price / Book0.0815.4510.486.42
Net Income-£3.88M-£22.82M£3.49B£5.89B
7 Day Performance0.46%-1.68%-0.68%0.20%
1 Month Performance-47.62%-6.15%-3.18%6.38%
1 Year Performance-94.36%30.67%15.13%19.26%

Futura Medical Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FUM
Futura Medical
N/AGBX 0.22
+10.0%		N/A-96.0%£1.28M£2.32MN/A12
TLM
Talisman Metals
N/AGBX 7.18
-1.0%		N/AN/A£4.61MN/A0.585
NFX
Nuformix
N/AGBX 0.15
-3.2%		N/A+32.0%£3.92MN/AN/A3
BNR
Burning Rock Biotech
N/AN/AN/AN/A£3.77MN/AN/A1,390
MTFB
Motif Bio
N/AN/AN/AN/A£3.28MN/AN/A6

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:FUM) was last updated on 9/24/2026 by MarketBeat.com Staff.
From Our Partners
Everyone remembers January's silver spike. Then what?
Silver is up more than 50 percent over the past year, yet interest has faded since its January record. The ...
i2i Marketing Group, LLC | Sponsoredtc pixel
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...
Porter & Company | Sponsoredtc pixel
While SpaceX Gets the Spotlight, FJET Is Building What Comes Next!
Starfighters Space (NYSE: FJET) operates the world's only commercial fleet of flight-ready Mach 2+ F-104 Starf...
Trading Wire | Sponsoredtc pixel
How to get a stake in Anthropic — before the IPO
Anthropic, the maker of Claude AI, has reportedly filed for an IPO that could arrive as early as October. Its ...
Weiss Ratings | Sponsoredtc pixel
They're shrinking your dollars every single month
Since 2020, the dollar has lost roughly a quarter of its buying power. A $500,000 nest egg today buys about wh...
American Alternative | Sponsoredtc pixel
Why I believe the AI market will split in Q4
Matt McCall, who recommended Nvidia near $6 a share, says the AI market is splitting in two - just like the do...
The Oxford Club | Sponsoredtc pixel
Arizona Gold Explorer Nears First-Ever Resource Estimate
A little-known Arizona gold explorer just hit 66.2 metres grading 6.57 g/t gold, including 20.7 metres at 18.2...
Wall Street Logic | Sponsoredtc pixel
Congress Passes Landmark Digital Asset Law Wall Street Is Watching
The House passed the Digital Asset Market Clarity Act 294 to 134, creating the most comprehensive financial te...
Awesomely | Sponsoredtc pixel